Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Abad

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
United European Gastroenterology Journal|August 5, 2024
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk populationPaula Iruzubieta, Rebeca Mayo, Itziar Mincholé, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2022
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histologyJosé L Calleja, Jesús Rivera-Esteban, Rocío Aller, et al.
Scientific Reports|August 13, 2016
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseRocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, et al.
Gastroenterologia Y Hepatologia|November 28, 2019
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEHRamón Bataller, Joaquín Cabezas, Rocío Aller, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2021
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjectsJavier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Gastroenterologia Y Hepatologia|April 11, 2018
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guidelineRocío Aller, Conrado Fernández-Rodríguez, Oreste Lo Iacono, et al.
Gastroenterologia Y Hepatologia|June 23, 2018
Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]Rocío Aller, Conrado Fernández-Rodríguez, Oreste Lo Iacono, et al.
United European Gastroenterology Journal|June 19, 2024
Fibroblast growth factor 21 is a hepatokine involved in MASLD progressionRocío Gallego-Durán, Javier Ampuero, Douglas Maya-Miles, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
United European Gastroenterology Journal|August 5, 2024
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk populationPaula Iruzubieta, Rebeca Mayo, Itziar Mincholé, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2022
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histologyJosé L Calleja, Jesús Rivera-Esteban, Rocío Aller, et al.
Scientific Reports|August 13, 2016
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseRocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, et al.
Gastroenterologia Y Hepatologia|November 28, 2019
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEHRamón Bataller, Joaquín Cabezas, Rocío Aller, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2021
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjectsJavier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Gastroenterologia Y Hepatologia|April 11, 2018
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guidelineRocío Aller, Conrado Fernández-Rodríguez, Oreste Lo Iacono, et al.
Gastroenterologia Y Hepatologia|June 23, 2018
Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]Rocío Aller, Conrado Fernández-Rodríguez, Oreste Lo Iacono, et al.
United European Gastroenterology Journal|June 19, 2024
Fibroblast growth factor 21 is a hepatokine involved in MASLD progressionRocío Gallego-Durán, Javier Ampuero, Douglas Maya-Miles, et al.
Pageof 3